Protalix BioTherapeutics
PLX
#8285
Rank
NZ$0.38 B
Marketcap
NZ$4.78
Share price
-2.94%
Change (1 day)
20.92%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): NZ$0.02662

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is NZ$0.03411. In 2024 the company made an earnings per share (EPS) of NZ$0.06822 a decrease over its 2023 EPS that were of NZ$0.20.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$0.02662-60.98%
2024NZ$0.06822-66.67%
2023NZ$0.20-138.71%
2022NZ-$0.53-50%
2021NZ-$1.06181.82%
2020NZ-$0.38-82.11%
2019NZ-$2.10-31.67%
2018NZ-$3.07-72.31%
2017NZ-$11.09124.14%
2016NZ-$4.95-147.54%
2015NZ$10.40-290.63%
2014NZ-$5.466.67%
2013NZ-$5.12130.77%
2012NZ-$2.22-69.77%
2011NZ-$7.3319.44%
2010NZ-$6.14-12.2%
2009NZ-$6.9936.67%
2008NZ-$5.12-37.5%
2007NZ-$8.1950%
2006NZ-$5.463.23%
2005NZ-$5.29138.46%
2004NZ-$2.22-74%
2003NZ-$8.53-0%
2002NZ-$8.53-50%
2001NZ-$17.06233.33%
2000NZ-$5.12-84.21%
1999NZ-$32.41-24%
1998NZ-$42.64-600%
1997NZ$8.53-16.67%
1996NZ$10.23

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.32 6,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$7.35 21,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ-$0.19-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.11 6,100.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel